Prevalence of extended-spectrum β-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran
- 1 February 2008
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 31 (2) , 147-151
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Resistance in Gram-Negative Bacteria: EnterobacteriaceaeThe American Journal of Medicine, 2006
- First description of CTX-M β-lactamase-producing clinical Escherichia coli isolates from EgyptInternational Journal of Antimicrobial Agents, 2006
- Regional variation in the prevalence of extended-spectrum β-lactamase–producing clinical isolates in the Asia-Pacific region (SENTRY 1998–2002)Diagnostic Microbiology and Infectious Disease, 2005
- Risk factors associated with extended-spectrum β-lactamase-producing organisms at a tertiary care hospitalJournal of Antimicrobial Chemotherapy, 2005
- Multidrug resistance in Gram-negative bacteria that produce extended-spectrum β-lactamases (ESBLs)Clinical Microbiology and Infection, 2005
- Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum β-lactamase in EuropeClinical Microbiology and Infection, 2003
- Extended-spectrum β-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitalsInternational Journal of Antimicrobial Agents, 2003
- Occurrence and Phenotypic Characteristics of Extended-Spectrum β-Lactamases among Members of the Family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and Evaluation of Diagnostic TestsJournal of Clinical Microbiology, 2003
- Variations in the Prevalence of Strains Expressing an Extended‐Spectrum β‐Lactamase Phenotype and Characterization of Isolates from Europe, the Americas, and the Western Pacific RegionClinical Infectious Diseases, 2001
- Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs)Clinical Microbiology and Infection, 2000